Mapi Posters

2012. ISPOR Annual International Meeting – The Cost-Effectiveness of Telaprevir (TVR) in Combination with Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Geneotype 1 (G1) Chronic Hepatitis C Patients.

Cure S, Curtis S, Bianic F, Gavart S, Dearden L, Fleischmann J, Ouwens M, Lee S. The Cost- Effectiveness of Telaprevir (TVR) in Combination with Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Geneotype 1 (G1) Chronic Hepatitis C Patients. Value Health. 2012 Jun;15(4):A241-A242. Presented at: ISPOR 17th Annual International Meeting; June 6, 2012; Washington DC, USA.